Advertisement
Advertisement
U.S. markets open in 7 hours 20 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Cannabix Technologies Inc. (BLOZF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3250+0.0059 (+1.86%)
At close: 03:42PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.3191
Open0.3281
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.3063 - 0.3328
52 Week Range0.2930 - 1.0000
Volume34,189
Avg. Volume68,515
Market Cap37.097M
Beta (5Y Monthly)1.99
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for BLOZF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • CANNABIX TECHNOLOGIES INC
    Analyst Report: Exact Sciences CorporationExact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact’s Cologuard screening test, a non-invasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a genetic-based treatment selection test for breast, prostate, and colon cancers. With the acquisitions of Base Genomics and Thrive Earlier Detection, Exact is building a multi-cancer early screening test to detect over 14 cancers, a test that would be one of earliest entrants in multi-cancer liquid biopsy cancer screening.
    Rating
    Fair Value
    Economic Moat
    14 days agoMorningstar
View more
  • Benzinga

    Cannabix: Developing A Solution For Outdated Marijuana Testing

    As we all know, the evolving legalization of medical and recreational cannabis in the United States and Canada is taking us into uncharted territory. As more laws allow the use of this drug, it is well worth considering how this will impact the safety of drivers, including whether our current methods of testing for THC (tetrahydrocannabinol, the compound largely responsible for the high that marijuana users experience) are really as fair and relevant as we need them to be. This is no small issue

Advertisement
Advertisement